K-numberK253307
Device nameElectric wheelchair
ApplicantFoshan Dahao Medical Technology Co., Ltd.
Product codeITI
Device classClass II
Decision dateMar 27, 2026
DecisionSubstantially Equivalent
Regulation890.3860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Electric Wheelchair (models DH01120, DH01105(4)) is a motor-driven vehicle designed for indoor and outdoor mobility assistance for disabled or elderly persons limited to a seated position. It features a lithium battery power system, joystick control, electromagnetic braking, and is composed of a frame, motor, controller, battery, and seat cushion.

Technological characteristics

The device has the same intended use, mode of action, and operational characteristics as the predicate device (K232193). Minor differences include slightly lower braking distance (≤1.0m vs ≤1.5m), lower max forward speed (4.5 km/h vs up to 6 km/h), lower maximum loading weight (100 kg vs 120 kg), and lower obstacle climbing ability (25mm vs 40mm). All other features—4-wheel configuration, joystick control, direct rear-wheel drive, electromagnetic braking, and 20 km range—are equivalent.

Test standards cited

Performance tested per ISO 7176 series (Parts 1-15, 21-22, 31), covering stability, braking effectiveness, energy consumption, speed, seating, structural strength, climatic performance, and lithium-ion battery systems. EMC/electrical safety tested per ISO 7176-21, IEC 60601-1-2:2014/AMD1:2020, ANSI C63.18-2014, and IEC 61000-4-39:2017. Biocompatibility assessed per FDA's 2023 Biocompatibility Guidance.

Substantial equivalence argument

The Electric Wheelchair is substantially equivalent to predicate device K232193 because it shares identical intended use, design principles, materials, and operational characteristics. Minor performance differences (lower speed, loading capacity, and obstacle climbing) do not raise new safety or effectiveness concerns and remain compliant with applicable ISO standards. Clinical testing was deemed unnecessary to demonstrate substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →